{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-22-027049","form_type":"8-K/A","ticker":"CC","cik":"0001627223","company_name":"Chemours Co","filed_at":"2022-12-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:51.487016+00:00","generated_at":"2026-06-20T22:52:09.956738+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Chemours board member Bell resigns over disagreement on abortion, transgender benefits","bullets":["Bradley J. Bell resigned effective Jan 2, 2023, citing moral opposition to employee benefits coverage for transgender procedures, abortions, and travel for abortion services.","Bell served on the Compensation Committee and Nominating and Corporate Governance Committee.","In his resignation letter, Bell called the benefits 'morally and ethically wrong' and stated he could not reconcile his board role with his beliefs.","Bell is involved with women's medical clinics opposing abortion; he questioned whether the benefits reflect employee demand or a cultural statement."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-22-027049","json":"https://secwatch.observer/filing/0000950170-22-027049.json","markdown":"https://secwatch.observer/filing/0000950170-22-027049.md","text":"https://secwatch.observer/filing/0000950170-22-027049.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1627223/000095017022027049/0000950170-22-027049-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1627223/000095017022027049/cc-20221221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T22:52:09.956738+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"e9b09d0c50","claim":"Bradley J. Bell resigned as Member of the Board of Directors at Chemours Co.","evidence_excerpt":"On December 21, 2022, Bradley J. Bell notified the Company of his decision to resign as a member of the Board of Directors of the Company effective as of January 2, 2023.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1627223/000095017022027049/0000950170-22-027049-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Member of the Board of Directors"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}